---
title: "AngioDynamics completes enrolment for PRESERVE clinical study"
date: "2023-08-03T14:53:48.000Z"
publishedDate: "3 août 2023"
summary: "AngioDynamics has announced the completion of enrolment and final treatment in its pivotal study of the NanoKnife system for ablation of prostate tissue in an intermediate-risk patient population (PRESERVE). The PRESERVE study was initiated by AngioDynamics."
importance: ""
sourceUrl: "https://interventionalnews.com/angiodynamics-completes-enrolment-for-preserve-clinical-study/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2023-08-03-angiodynamics-completes-enrolment-for-preserve-clinical-study"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2022/08/AngioDynamics-logo-766x512-1.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/angiodynamics-completes-enrolment-for-preserve-clinical-study/"
---

![AngioDynamics completes enrolment for PRESERVE clinical study](https://interventionalnews.com/wp-content/uploads/sites/13/2022/08/AngioDynamics-logo-766x512-1.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/angiodynamics-completes-enrolment-for-preserve-clinical-study/*

## L’essentiel

AngioDynamics has announced the completion of enrolment and final treatment in its pivotal study of the NanoKnife system for ablation of prostate tissue in an intermediate-risk patient population (PRESERVE). The PRESERVE study was initiated by AngioDynamics.

## Lien source

https://interventionalnews.com/angiodynamics-completes-enrolment-for-preserve-clinical-study/
